Military Medicine
December 24, 2022
Joshua C. Gray, Mikela A. Murphy, Sierra Carter et al.
10 citations
ABSTRACT Introduction Posttraumatic stress disorder (PTSD) and depression are common in service members and veterans, and the response to currently available treatments is often modest at best. Recent studies suggest potential benefit with psychedelic-assisted therapies (PATs), particularly 3,4-methylenedioxymethamphetamine-assisted therapy for PTSD and psilocybin-assisted therapy for...
Trauma Care
December 22, 2022
Michelle M. Lepak
Trauma can result in many long-term symptoms including emotional dysregulation, depression, addiction, and PTSD. When triggered by trauma, patients typically experience the world through a myopic lens. Helping clients observe and sense their trauma sequelae in the broader sensory awareness of Presence appears to help clients more easily process and resolve traumatic experience. The Presence...
Psychiatry Research
December 21, 2022
Youge Qu, Akifumi Eguchi, Xiayun Wan et al.
3,4-Methylenedioxymethamphetamine (MDMA), the most widely used illicit compound worldwide, is the most attractive therapeutic drug for post-traumatic stress disorder (PTSD). Recent observational studies of US adults demonstrated that lifetime MDMA use was associated with lower risk of depression. Here, we examined whether repeated administration of MDMA can affect resilience versus...
Journal of Psychedelic Studies
December 8, 2022
A. Atoian, Harry C. R. Bowles, Sarah Gerhke et al.
The COVID-19 pandemic exacerbated pre-existing high-levels of physician stress and burnout1. In order to help treat frontline colleagues who were diagnosed with acute stress disorder, we chose a non-psychedelic, ketamine micro-dose treatment strategy for symptom management.We provided care virtually, and all patients were prescribed sublingual ketamine once daily. Each patient was evaluated...
Neurosurgery
December 8, 2022
Akanksha Sharma, Shanthi Gowrinathan, Karina Sergi et al.
13 citations
After a decades-long pause, psychedelics are again being intensely investigated for treating a wide range of neuropsychiatric ailments including depression, anxiety, addiction, post-traumatic stress disorder, anorexia, and chronic pain syndromes. The classic serotonergic psychedelics psilocybin and lysergic acid diethylamide and nonclassic psychedelics 3,4-methylenedioxymethamphetamine and...
Frontiers in Psychiatry
December 5, 2022
Elliot Marseille, Stefano Bertozzi, James G. Kahn
51 citations
After a long hiatus, psychiatry is undergoing a resurgence of interest in psychedelic drugs as therapy for a wide range of mental health disorders Accumulating clinical evidence suggests substantial potential for psychedelics used in a therapeutic context, as treatment for, among other disorders, depression, post-traumatic stress disorder (PTSD), and addictions to tobacco, opioids and alcohol....
Journal of the Association of Physicians of India
December 1, 2022
Gouranga Santra
18 citations
INTRODUCTION: Growing evidences of the health benefits of yoga are available in the literature. But physicians are not aware of it. METHODOLOGY: Databases like PubMed, PubMed Central, Google Scholar, and Scopus are searched for the articles on preventive, therapeutic, and rehabilitation potential of yoga. Scientific evidences available are analyzed and incorporated into the article. RESULT:...
Current Psychiatry
December 1, 2022
Madonna Thakur
3 citations
SAM FALCONERP sychedelics are a class of substances known to produce alterations in consciousness and perception.In the last 2 decades, psychedelic research has garnered increasing attention from scientists, therapists, entrepreneurs, and the public.While many of these compounds remain illegal in the United States and in many parts of the world (Box, 1 page 16), a recent resurrection of...
Neuroscience & Biobehavioral Reviews
December 1, 2022
Steven Kotler, Michael Mannino, Scott Kelso et al.
44 citations
Flow is a cognitive state that manifests when there is complete attentional absorption while performing a task. Flow occurs when certain internal as well as external conditions are present, including intense concentration, a sense of control, feedback, and a balance between the challenge of the task and the relevant skillset. Phenomenologically, flow is accompanied by a loss of...
Applied and Environmental Microbiology
November 29, 2022
Virginia Ramírez-Cruz, Giuliana Furci, Paul Stamets et al.
29 citations
The therapeutic use of psilocybin, the active ingredient in “magic mushrooms,” is revolutionizing mental health care for a number of conditions, including depression, posttraumatic stress disorder (PTSD), and end-of-life care. This has spotlighted the current state of knowledge of psilocybin, including the organisms that endogenously produce it.